Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: RANI) | Delayed: 0.60 -0.01 (1.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.61 | 52 Week High | $ | |||
| Open | $0.62 | 52 Week Low | $ | |||
| Day High | $0.63 | P/E | N/A | |||
| Day Low | $0.59 | EPS | $ | |||
| Volume | 208,095 | |||||
